Omaxe Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Omaxe (NSE: OMAXE) is preparing to announce its Q4 FY26 financial results for the quarter ended March 31, 2026. With Omaxe trading at Rs 118 — against a 52-week high of Rs 235 and a 1-year return of -42% — the Q4 FY26 results will be a pivotal event for investors in the Real Estate sector.

Analyst estimates for Q4 FY26 revenue stand at Rs 400–480 Cr, with PAT expectations of Rs 10–20 Cr and margin projections of EBITDA 12–16%. This article covers the Omaxe Q4 results 2026 date, detailed earnings estimates, five key performance factors, five risks to monitor, analyst ratings and price targets, and answers to the most commonly searched investor questions.

Get free investment predictions and live Q4 result alerts on Univest.

Omaxe Q4 Results 2026 Date

Omaxe has scheduled its Q4 FY26 results for May 2026 (Expected). The board of directors will meet on this date to approve the audited financial statements for the quarter ended March 31, 2026, and to consider a final dividend recommendation. At a current market price of Rs 118, investors and analysts are closely watching this announcement for revenue growth confirmation and FY27 guidance.

Why This Quarter Matters

Q4 is the final quarter of the financial year — it determines full-year FY26 performance, sets the FY27 estimate base, and triggers final dividend announcements. For Omaxe, which operates in the Real Estate sector, Q4 FY26 will reveal whether momentum from earlier quarters has been sustained and whether management’s strategic initiatives have translated into financial outcomes.

At a 1-year return of -42%, this quarter’s results and FY27 guidance will be critical in determining whether the stock can begin a recovery. Investors will watch for order pipeline updates, margin trajectory, and capex guidance — any positive surprise on multiple parameters could drive a meaningful post-results re-rating.

Omaxe Q4 FY26 Earnings Estimates

Omaxe Q4 FY26 Analyst Estimates at a Glance | Source: MOFSL, YES Securities, JM Financial

Access premium SEBI-registered research on Univest.

Analysts covering Omaxe have published Q4 FY26 estimates based on Q3 FY26 actuals, sector trends, and company-specific catalysts. Consensus estimates point to revenue of Rs 400–480 Cr, PAT of Rs 10–20 Cr, and margins of EBITDA 12–16%. These projections reflect both the seasonal strength of Q4 and ongoing structural improvements in Omaxe’s business model.

Beyond headline numbers, investors will closely monitor FY27 guidance commentary, order book evolution, working capital trends, and any one-time items that could inflate or suppress reported PAT. A clean recurring profit print is more positively received by the market than results driven by non-operational gains.

Screen Omaxe fundamentals on Univest Screener.

5 Key Factors That Will Drive Omaxe Q4 FY26 Performance

Sports City and Integrated Township Projects

Omaxe’s flagship Dwarka Sports City project in Delhi-NCR and its integrated townships in tier-2 cities of North India are the primary revenue drivers. Q4 FY26 will reflect sales bookings, project completions, and revenue recognition from these large-format developments. Any acceleration in project deliveries would boost PAT and improve investor confidence.

Pre-Sales and Booking Momentum

Real estate developers are valued on pre-sales (bookings) performance. Q4 FY26 is traditionally a strong booking quarter as buyers finalise decisions before the financial year end. Omaxe’s affordable and mid-income housing projects in cities like Lucknow, Indore, and Faridabad benefit from the Pradhan Mantri Awas Yojana (PMAY) demand pool.

Debt Reduction Progress

Omaxe has historically carried high debt, which has weighed on investor sentiment. Q4 FY26 results will be scrutinised for progress on debt reduction. Any meaningful reduction in net debt levels — driven by project collection inflows — would be a strong positive catalyst for the stock, which has underperformed peers significantly.

Revenue Recognition from Under-Construction Projects

Real estate revenue recognition in India follows the percentage completion method. Q4 FY26 will reflect construction milestone-based revenue from Omaxe’s projects across UP, MP, and Punjab. Management commentary on construction timelines and RERA compliance will be watched by investors.

Regulatory and RERA Compliance

RERA compliance and timely project delivery are critical for real estate companies. Omaxe’s track record on delivery timelines and RERA compliance will influence buyer confidence, sales velocity, and collection efficiency — all feeding into Q4 FY26 financial performance.

5 Risks to Watch in Omaxe Q4 FY26

High Debt and Interest Burden

Omaxe’s elevated debt levels generate significant interest expenses that compress PAT even when EBITDA recovers. The company’s ability to service debt from project cash flows is a key investor concern.

Project Execution Delays

Real estate project delays are common in India. Any delays in Omaxe’s flagship projects would push revenue recognition and collection beyond Q4 FY26 estimates.

Demand Risk in Tier-2 Cities

Omaxe’s exposure to tier-2 and tier-3 cities creates demand risk during economic slowdowns. If job market conditions soften, housing demand in these markets could weaken more than tier-1 cities.

Unsold Inventory Overhang

Elevated unsold inventory in existing projects could weigh on developer margins through discounting pressure. High inventory levels also indicate slower-than-expected demand absorption.

Funding Risk and Credit Rating

Real estate companies depend heavily on bank lending and customer advances. Any credit rating downgrade or tightening of credit conditions could increase funding costs and impact project execution.

Omaxe Share Price and Analyst Ratings

Omaxe Share Price & Analyst Ratings | Source: NSE/BSE, Broker Notes

Omaxe is trading at Rs 118 as of early April 2026, against a 52-week high of Rs 235 and 52-week low of Rs 95. Market cap stands at Rs 2,180 Cr. The 1-year return of -42% reflects sector headwinds alongside company-specific factors. Analyst price targets range from the conservative to the optimistic, reflecting differing views on the pace of business recovery and margin expansion.

Download the Univest iOS App or Univest Android App to track Omaxe’s live price and receive real-time Q4 result alerts.

Conclusion

Omaxe Q4 FY26 results are expected to show a return to profitability after Q3’s loss, driven by Sports City and township project deliveries. At Rs 118, the stock trades at a steep discount to book value, with high debt being the primary investor concern. A meaningful PAT positive print combined with debt reduction progress would trigger a re-rating. Investors should closely monitor collections, receivables, and debt metrics alongside headline revenue. Consult a SEBI-registered advisor before investing.

This content is published by Univest, a SEBI-registered research and advisory platform. All analyst estimates and price targets cited are from publicly available broker notes. Past performance is not indicative of future results. Investors should conduct independent due diligence before making any investment decisions.

For more Q4 FY26 previews across IT, banking, auto, pharma, and cement sectors, visit Univest Blogs.

Frequently Asked Questions

What is the Omaxe Q4 results 2026 date?

Omaxe Q4 FY26 results are scheduled for May 2026 (Expected). The board of directors will meet on this date to approve the audited financial statements and consider a dividend recommendation for FY26.

What is the Omaxe Q4 FY26 PAT estimate?

Analysts estimate Omaxe Q4 FY26 net profit (PAT) in the range of Rs 10–20 Cr. This estimate is based on revenue assumptions of Rs 400–480 Cr and a margin of EBITDA 12–16%. Actual results may differ from these consensus estimates.

What is Omaxe’s share price ahead of Q4 results?

Omaxe shares are trading at approximately Rs 118 as of early April 2026. The 52-week high is Rs 235 and the 52-week low is Rs 95. The one-year return is -42% and the market cap stands at Rs 2,180 Cr.

Will Omaxe declare a dividend in Q4 2026?

Omaxe is expected to consider a dividend of Nil expected at the Q4 FY26 board meeting on May 2026 (Expected). The quantum signals management’s confidence in free cash flow generation for FY26.

Which analysts have a Buy rating on Omaxe?

Refer to latest broker notes have positive ratings on Omaxe ahead of Q4 FY26 results.

What were Omaxe Q3 FY26 results?

In Q3 FY26, Omaxe reported revenue of Rs 348 Cr and PAT of Rs -8 Cr, with margins at EBITDA 12.5%. These numbers provided the base for Q4 FY26 estimates and analyst coverage updates.

When do Infosys and TCS announce Q4 results 2026?

TCS announced Q4 FY26 results on April 9, 2026. See the full TCS Q4 Results 2026 preview. Infosys announced Q4 FY26 results on April 23, 2026.

Is Omaxe a good investment ahead of Q4 results?

Omaxe at Rs 118 offers a risk-reward that depends on Q4 execution and FY27 guidance. Investors should review the analyst estimates, monitor the results announcement, and consult a SEBI-registered advisor before making investment decisions. Past performance is not indicative of future results.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Article

Motisons Jewellers Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Motilal Oswal Financial Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Moschip Technologies Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morepen Laboratories Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morarjee Textiles Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook